Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Stopped early · Phase 3
Conditions studied: Relapsing Remitting Multiple Sclerosis
In brief
This was a multicenter, randomized, open-label, parallel-group, active-controlled study. Prior to randomization, participants were to have been treated with glatiramer acetate or interferon β-1a (44 μg). Participants were to be randomized to receive natalizumab, interferon β-1a 44 μg, or glatiramer acetate.
Key facts
- Study ID
- NCT01058005
- Run by
- Biogen
- People needed
- 84
- Starts
- 2010-03-01
- Expected to finish
- 2012-04-01
- Last updated by the study team
- 2014-09-03
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Cullman, Alabama, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Fort Collins, Colorado, United States
- Research Site — Maitland, Florida, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — New Orleans, Louisiana, United States
- Research Site — Detroit, Michigan, United States
- Research Site — Patchogue, New York, United States
- Research Site — Charlotte, North Carolina, United States
- Research Site — Akron, Ohio, United States
- Research Site — Franklin, Tennessee, United States
- Research Site — Knoxville, Tennessee, United States
- Research Site — Round Rock, Texas, United States
- Research Site — Norfolk, Virginia, United States
- Research Site — Kirkland, Washington, United States
- Research Site — Morgantown, West Virginia, United States
- Research Site — Fitzroy, Victoria, Australia
- Research Site — Gatineau, Quebec, Canada
- Research Site — Pardubice, Czechia
- Research Site — Tampere, Finland
- Research Site — Strasbourg, Bas-Rhin, France
- Research Site — Esztergom, Komárom-Esztergom, Hungary
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.